Shinya Goto/LinkedIn
Sep 15, 2026, 01:58
Shinya Goto: Country Specific Randomized Trial Show the Merit of DOAC in Intermediate Risk of A
Shinya Goto, Director and Chairman in Metabolic Disease Research Center, shared a post on LinkedIn about a recent article by Daehoon Kim et al., published in The New England Journal of Medicine, adding:
“Country specific randomized trial show the merit of DOAC in intermediate risk of A”
Title: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk
Authors: Daehoon Kim, Young Soo Lee, Jaemin Shim, Hee Tae Yu, Junbeom Park, Jin-Kyu Park, Il-Young Oh, Ki-Woon Kang, Eue-Keun Choi, Kyoung-Min Park, Hyoung-Seob Park, Dae-Hyeok Kim, Hyung Wook Park, Jun Kim, Jum-Suk Ko, Dongmin Kim, Jong-Youn Kim, Jin-Bae Kim, Jung-Hoon Sung, Tae-Hoon Kim, Jae-Sun Uhm, Hui-Nam Pak, Boyoung Joung

Other posts featuring Shinya Goto on Hemostasis Today.
Boyoung Joung
Dae-Hyeok Kim
Daehoon Kim
Dongmin Kim
Eue-Keun Choi
Health
Hee Tae Yu
Hematology
Hemostasis
Hemostasis News
Hemostasis Today
Hui-Nam Pak
Hyoung-Seob Park
Hyung Wook Park
Il-Young Oh
Jae-Sun Uhm
Jaemin Shim
Jin-Bae Kim
Jin-Kyu Park
Jong-Youn Kim
Jum-Suk Ko
Jun Kim
Junbeom Park
Jung-Hoon Sung
Ki-Woon Kang
Kyoung-Min Park
Medicine
NEJM
Shinya Goto
Tae-Hoon Kim
The New England Journal of Medicine
Young Soo Lee
-
Sep 15, 2026, 02:59Caterina Casari: Curious about How Gene Editing is Revolutionizing Our Field?
-
Sep 15, 2026, 02:53Alejandro González Veliz: Can Lifestyle Changes Actually Reverse Atherosclerosis?
-
Sep 15, 2026, 02:08Eugenia Gianos: ACC CVPrevention Council’s New Statin Resources
-
Sep 15, 2026, 01:37Lesley Van Wyk: Exploring Sickle Cell Disease – The HbS Story
-
Sep 15, 2026, 01:31Luca Seffin: To the Science, the People, and the Journey – Thank You SR-Tiget
-
Sep 14, 2026, 23:49Heghine Khachatryan: New evidance – Antiphospholipid Antibodies and Ischemic Stroke
-
Sep 14, 2026, 23:42Eman M. Elsabbagh: Successful HCT Does Not End at Engraftment
-
Sep 14, 2026, 23:31Antonis Kattamis: Proud to Be Part of this Endeavour and Senior Author of the Pivotal Trial
-
Sep 14, 2026, 23:23Farjah Algahtani: Stroke Incidence and Risk Factors in Saudi Patients with Sickle Cell Disease